These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14758774)

  • 21. Emerging roles of DP and CRTH2 in allergic inflammation.
    Kostenis E; Ulven T
    Trends Mol Med; 2006 Apr; 12(4):148-58. PubMed ID: 16545607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of diverse actions of prostanoid receptors.
    Negishi M; Sugimoto Y; Ichikawa A
    Biochim Biophys Acta; 1995 Oct; 1259(1):109-19. PubMed ID: 7492609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic Regulation in Adipocytes by Prostanoid Receptors.
    Inazumi T; Sugimoto Y
    Biol Pharm Bull; 2022; 45(8):992-997. PubMed ID: 35908909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diphenylmethylazine prostanoids with prostacyclin-like actions on human platelets.
    Jones RL; Wilson NH; Marr CG; Muir G; Armstrong RA
    J Lipid Mediat; 1993; 6(1-3):405-10. PubMed ID: 8357998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2.
    Hata AN; Lybrand TP; Marnett LJ; Breyer RM
    Mol Pharmacol; 2005 Mar; 67(3):640-7. PubMed ID: 15563582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional pharmacology of human prostanoid EP2 and EP4 receptors.
    Wilson RJ; Rhodes SA; Wood RL; Shield VJ; Noel LS; Gray DW; Giles H
    Eur J Pharmacol; 2004 Oct; 501(1-3):49-58. PubMed ID: 15464062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tachykinins and tachykinin receptors: effects in the genitourinary tract.
    Candenas L; Lecci A; Pinto FM; Patak E; Maggi CA; Pennefather JN
    Life Sci; 2005 Jan; 76(8):835-62. PubMed ID: 15589963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin receptors mediate effects of substances released from ischaemic rat hearts on non-ischaemic cardiomyocytes.
    Birkenmeier K; Janke I; Schunck WH; Trimpert C; Krieg T; Landsberger M; Völker U; Felix SB; Staudt A
    Eur J Clin Invest; 2008 Dec; 38(12):902-9. PubMed ID: 19021714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The constitutive activity of ghrelin receptors is decreased by co-expression with vasoactive prostanoid receptors when over-expressed in human embryonic kidney 293 cells.
    Chow KB; Leung PK; Cheng CH; Cheung WT; Wise H
    Int J Biochem Cell Biol; 2008; 40(11):2627-37. PubMed ID: 18573679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
    Coleman RA; Smith WL; Narumiya S
    Pharmacol Rev; 1994 Jun; 46(2):205-29. PubMed ID: 7938166
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostanoid receptors in human uterine myocytes: the effect of reproductive state and stretch.
    Sooranna SR; Grigsby P; Myatt L; Bennett PR; Johnson MR
    Mol Hum Reprod; 2005 Dec; 11(12):859-64. PubMed ID: 16421214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.
    Hirano Y; Shichijo M; Deguchi M; Nagira M; Suzuki N; Nishitani Y; Hattori M; Arimura A
    Eur J Pharmacol; 2007 Mar; 560(1):81-8. PubMed ID: 17307163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cyclooxygenase inhibition on the gastrointestinal tract.
    Radi ZA; Khan NK
    Exp Toxicol Pathol; 2006 Nov; 58(2-3):163-73. PubMed ID: 16859903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostanoid receptors: ontogeny and implications in vascular physiology.
    Wright DH; Abran D; Bhattacharya M; Hou X; Bernier SG; Bouayad A; Fouron JC; Vazquez-Tello A; Beauchamp MH; Clyman RI; Peri K; Varma DR; Chemtob S
    Am J Physiol Regul Integr Comp Physiol; 2001 Nov; 281(5):R1343-60. PubMed ID: 11641101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
    Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
    Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.
    Errasti AE; del-Rey G; Cesio CE; Souza G; Nowak W; Pelorosso FG; Daray FM; Rothlin RP
    Eur J Pharmacol; 2009 May; 610(1-3):68-74. PubMed ID: 19289115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation.
    Behm DJ; Ogbonna A; Wu C; Burns-Kurtis CL; Douglas SA
    J Pharmacol Exp Ther; 2009 Jan; 328(1):231-9. PubMed ID: 18836067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of prostanoids in urinary bladder physiology.
    Rahnama'i MS; van Kerrebroeck PE; de Wachter SG; van Koeveringe GA
    Nat Rev Urol; 2012 Mar; 9(5):283-90. PubMed ID: 22410675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantio- and stereospecific syntheses of 15(R)-Me-PGD2, a potent and selective DP2-receptor agonist.
    Patel P; Lee GJ; Kim S; Grant GE; Powell WS; Rokach J
    J Org Chem; 2008 Sep; 73(18):7213-8. PubMed ID: 18700746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostanoids and their receptors that modulate dendritic cell-mediated immunity.
    Gualde N; Harizi H
    Immunol Cell Biol; 2004 Aug; 82(4):353-60. PubMed ID: 15283844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.